Verrica Pharmaceuticals Inc
VRCA
Get informed when a big investor buys or sells
+ FollowMarket Cap$61.35M
Close$
$-4.80
181.8% downside
Current Fair Value
181.8% downsideOvervalued by 181.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $61.35 Million |
|---|---|
| Enterprise Value | $43.23 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.68 |
| Beta | 1.55 |
| Outstanding Shares | 10,652,367 |
Return
| Return on Equity | -111.03% |
|---|---|
| Return on Assets | -45.96% |
| Return on Invested Capital | -55.42% |
Valuation & Multiples
| P/E Ratio | -3.44 |
|---|---|
| PEG | 558.87 |
| Price to Sales | 1.96 |
| Price to Book Ratio | 5.87 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | -3.46 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.46
Average shareholder expectationRevenue Estimate
$5.55 M
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
$5.90 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 44.85%▼ 9.90% |
|---|---|
| Total Invested | $25.28M▼ 41.43% |
| Investors Holding | 39▼ 10.00% |
ESG Score
No data
About Verrica Pharmaceuticals Inc
CEO: Ted White